| Vergos Vision Service Inc | |
|
3385 S Center Rd, Burton, MI 48519-1457 | |
| (810) 244-3434 | |
| (810) 715-0301 |
| Full Name | Vergos Vision Service Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 3385 S Center Rd, Burton, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447511456 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 4901003310 (Michigan) | Primary |
| Provider Name | Peter G Vergos |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1669444840 PECOS PAC ID: 1850389321 Enrollment ID: I20040504000344 |
News Archive
Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient's response to therapy.
The behaviour of immune cells in the blood is so different in patients with Parkinson's disease that it advocates for a new type of supplementary medicine, which can regulate the immune system and thus inhibit the deterioration of the brain.
Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.
Gilead Sciences Inc's four-drug experimental HIV pill worked as well as a regimen containing protease inhibitor Reyataz in the second pivotal trial of the drug, the company announced this Monday. Although the trial succeeded, it did not show the experimental pill, called the Quad, was superior to the Reyataz regimen and Gilead shares fell less than a percentage point.
People with depression or bipolar disorder often feel their thinking ability has gotten "fuzzy", or less sharp than before their symptoms began. Now, researchers have shown in a very large study that effect is indeed real - and rooted in brain activity differences that show up on advanced brain scans.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vergos Vision Service Inc 3385 S Center Rd, Burton, MI 48519-1457 Ph: (810) 244-3434 | Vergos Vision Service Inc 3385 S Center Rd, Burton, MI 48519-1457 Ph: (810) 244-3434 |
News Archive
Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient's individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient's response to therapy.
The behaviour of immune cells in the blood is so different in patients with Parkinson's disease that it advocates for a new type of supplementary medicine, which can regulate the immune system and thus inhibit the deterioration of the brain.
Newly published data shows using a Respiratory Modulation Response (RMR) is a novel, non-invasive measure to quickly and accurately detect the presence of significant coronary artery disease (sCAD). Patients in the study with sCAD had a lower RMR compared to patients without, regardless of their risk factors or clinical history of angina, previous myocardial infarction (MI), or angioplasty.
Gilead Sciences Inc's four-drug experimental HIV pill worked as well as a regimen containing protease inhibitor Reyataz in the second pivotal trial of the drug, the company announced this Monday. Although the trial succeeded, it did not show the experimental pill, called the Quad, was superior to the Reyataz regimen and Gilead shares fell less than a percentage point.
People with depression or bipolar disorder often feel their thinking ability has gotten "fuzzy", or less sharp than before their symptoms began. Now, researchers have shown in a very large study that effect is indeed real - and rooted in brain activity differences that show up on advanced brain scans.
› Verified 2 days ago
Dr. Jonathon David Connors, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1235 S Center Rd Ste 16, Burton, MI 48509 Phone: 810-744-1950 Fax: 810-744-1515 | |
General Optical Company Optometrist Medicare: Medicare Enrolled Practice Location: 1235 S Center Rd, Suite 16, Burton, MI 48509 Phone: 810-744-1950 Fax: 810-744-1515 | |
Dr Todd W Lee O D P C Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5323 E Court St N, Burton, MI 48509 Phone: 810-744-9596 | |
Dr. Mark D. Engelman, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3385 S Center Rd, Burton, MI 48519 Phone: 810-244-3434 Fax: 810-715-0301 | |
Christopher Kowalski, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1235 S Center Rd, Suite 16, Burton, MI 48509 Phone: 810-744-1950 | |
Casey L Coulter, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4165 E Court St, Burton, MI 48509 Phone: 810-743-1267 | |
Ross H Williams, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4067 E Court St, Suite 10, Burton, MI 48509 Phone: 810-230-1600 Fax: 810-715-2021 |